Skip to main content

Advertisement

SpringerLink
Log in

Human papillomavirus type 16 (HPV 16) E7 and major histocompatibility complex (MHC) class I and II expression in human keratinocytes in culture

  • Original Papers
  • Published:
Archives of Virology Aims and scope Submit manuscript

Summary

The low expression of major histocompatibility complex (MHC) class I antigens on human papillomavirus (HPV)-infected cervical carcinoma cells may be responsible for an insufficient cytotoxic T cell response against these cells. To investigate in vitro whether the HPV type 16 early gene product E7 influences cell surface expression of MHC class I and II molecules the HPV negative keratinocyte cell line HaCaT was either stably transfected with the E7 gene or infected with E7-recombinant vaccinia viruses. No difference in MHC class I transcription was detected between E7-transfected and untransfected HaCaT cells. MHC class I cell surface expression as determined by FACS analysis was stronger in some of the transfectants and less intensive in others when compared to untransfected HaCaT cells. In wildtype as well as in E7-recombinant vaccinia virus infected HaCaT cells downregulation of MHC class I molecules on protein and transcriptional level was observed. The alterations in MHC class I expression were independent of the presence and amount of E7-specific transcripts. None of the transfectants or infected HaCaT cells had MHC class II molecules on their cell surface. Hence, our data did not show a correlation between HPV 16 E7 and MHC expression in vitro.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. zur Hausen H (1991) Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184: 9–13

    PubMed  Google Scholar 

  2. Jochmus I, Altmann A (1993) Immune response to papillomaviruses: prospects of an anti-HPV vaccine. Papillomavirus Rep 4: 147–151

    Google Scholar 

  3. Ruiz-Cabello F, Klein E, Garrido F (1991) MHC antigens on human tumors. Immunol Lett 29: 181–190

    PubMed  Google Scholar 

  4. Connor ME, Stern PL (1990) Loss of MHC class I expression in cervical carcinomas. Int J Cancer 46: 1029–1034

    PubMed  Google Scholar 

  5. Glew S, Duggan-Keen M, Cabrera T, Stern PL (1992) HLA class II antigen expression in human papillomavirus-associated cervical cancer. Cancer Res 36: 4009–4016

    Google Scholar 

  6. Cromme FV, Meijer CJLM, Snijders PJF, Uyterlinde A, Kenemans P, Helmerhorst T, Stern PL, van den Brule AJC, Walboomers JMM (1993a) Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions. Br J Cancer 67: 1372–1380

    PubMed  Google Scholar 

  7. Cromme FV, Snijders PJF, van den Brule AJC, Kenemans P, Meijer CJLM, Walboomers JMM (1993b) MHC class I expression in HPV 16 positive cervical carcinomas is posttranscriptionally controlled and independent from c-myc overexpression. Oncogene 8: 2969–2975

    PubMed  Google Scholar 

  8. Oldstone MB (1991) Molecular anatomy of viral persistence. J Virol 65: 6381–6386

    PubMed  Google Scholar 

  9. Maudsley DJ, Pound JD (1991) Modulation of MHC antigen expression by viruses and oncogenes. Immunol Today 12: 429–431

    PubMed  Google Scholar 

  10. Meijer I, Jochemsen AG, de Wit CM, Bos JL, Morello D, van der Eb AJ (1989) Adenovirus type 12 E1A downregulates expression of a transgene under the control of a major histocompatibility complex class I promotor: evidence for transcriptional control. J Virol 63: 4039–4042

    PubMed  Google Scholar 

  11. Rotem-Yehudar R, Winograd S, Sela S, Coligan JE, Ehrlich R (1994) Downregulation of peptide transporter genes in cell lines transformed with the highly oncogenic adenovirus 12. J Exp Med 180: 477–488

    PubMed  Google Scholar 

  12. Schouten GJ, van der Eb AJ, Zantema A (1995) Downregulation of MHC class I expression due to interference with p105-NFκB1 processing by Ad12E1A. EMBO J 14: 1498–1507

    PubMed  Google Scholar 

  13. Vousden KH, Jat PS (1989) Functional similarity between HPV 16 E7, SV40 large T and adenovirus E1a proteins. Oncogene 4: 153–158

    PubMed  Google Scholar 

  14. Phelps WC, Münger K, Yee CL, Barnes JA, Howley PM (1992) Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein. J Virol 66: 2418–2427

    PubMed  Google Scholar 

  15. Boukamp P, Petroussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106: 761–771

    PubMed  Google Scholar 

  16. Miller AD, Rosman GJ (1989) Improved retroviral vectors for gene transfer and expression. Biotechniques 7: 980–990

    PubMed  Google Scholar 

  17. Mackett M, Smith GL, Moss B (1985) The construction and characterization of vaccinia virus recombinants expressing foreign genes. In: Glover DM (ed) DNA cloning: a practical approach. IRL Press, Oxford, pp 191–211

    Google Scholar 

  18. Panicali D, Paoletti E (1982) Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia viruses. Proc Natl Acad Sci USA 79: 4927–4931

    PubMed  Google Scholar 

  19. Falkner FG, Moss B (1988) Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors. J Virol 62: 1849–1854

    PubMed  Google Scholar 

  20. Chomczynski P, Sacchi N (1987) Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chlorophorm extraction. Anal Biochem 162: 156–159

    PubMed  Google Scholar 

  21. Lämmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–685

    PubMed  Google Scholar 

  22. Barnstable CJ, Bodmer WF, Brown G, Galfre G, Milstein C, Williams AF, Ziegler A (1978) Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens — new tools for genetic analysis. Cell 14: 9–20

    PubMed  Google Scholar 

  23. Hilders CGJM, Houbiers JGA, Krul EJT, Fleuren GJ (1994) The expression of histocompatibility-related leucocyte antigens in the pathway to cervical carcinoma. Am J Clin Pathol 101: 5–12

    Google Scholar 

  24. Cromme FV, van Bommel PFJ, Walboomers JMM, Gallee MPW, Stern PL, Kenemans P, Helmerhort TJM, Stukart MJ, Meijer CJLM (1994) Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumors. Br J Cancer 69: 1176–1181

    PubMed  Google Scholar 

  25. Pan H, Griep E (1994) Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. Genes Dev 8: 1285–1299

    PubMed  Google Scholar 

  26. Howes AA, Ransom N, Papermaster DS, Lasudry JGH, Albert DM, Windle JJ (1994) Apoptosis or retinoblastoma: alternative rates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. Genes Dev 8: 1300–1310

    PubMed  Google Scholar 

  27. Jochmus I, Dürst M, Reid R, Altmann A, Bijward KE, Gissmann L, Jenson AB (1993) Major histocompatibility complex and human papillomavirus type 16 E7 expression in high grade vulvar lesions. Hum Pathol 24: 519–524

    Google Scholar 

  28. Levitskaya J, Coram M, Levitsky V, Imreh S, Steigerwald-Mullen PM, Klein G, Kurilla MG, Masucci MG (1995) Inhibition of antigen processing by an internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375: 685–688

    PubMed  Google Scholar 

  29. Malejczyk J, Malejczyk M, Majewski S, Orth G, Jablonska S (1993) NK-cell activity in patients with HPV 16-associated anogenital tumors: defective recognition of HPV 16-harboring keratinocytes and restricted unresponsiveness to immunostimulatory cytokines. Int J Cancer 54: 917–921

    PubMed  Google Scholar 

Download references

Author information

Author notes

  1. C. D'Incan

    Present address: Laboratoire d'oncologie moleculaire, INSERM CRI9402, Centre Jean Perrin, Clermont-Ferrand, France

  2. I. Nindl

    Present address: Universitäts-Frauenklinik, Molekularbiologisches Labor, Jena, Germany

  3. BH. Schönning

    Present address: The Protein Laboratory, Panum Institute, Copenhagen, Denmark

Authors and Affiliations

  1. Deutsches Krebsforschungszentrum, Forschungsschwerpunkt Angewandte Tumorvirologie, Heidelberg, Germany

    A. Hoos, C. D'Incan, L. Gissmann, A. Altmann, F. Momburg, I. Nindl, W. Osen, BH. Schönning & I. Jochmus

  2. Loyola University Medical Center, Obstetrics and Gynecology, Maywood, Illinois, USA

    L. Gissmann

  3. Deutsches Krebsforschungszentrum, Forschungsschwerpunkt Tumorimmunologie, Heidelberg, Germany

    F. Momburg

Authors
  1. A. Hoos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. D'Incan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. Gissmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Altmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F. Momburg
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. I. Nindl
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. W. Osen
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. BH. Schönning
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. I. Jochmus
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hoos, A., D'Incan, C., Gissmann, L. et al. Human papillomavirus type 16 (HPV 16) E7 and major histocompatibility complex (MHC) class I and II expression in human keratinocytes in culture. Archives of Virology 141, 449–458 (1996). https://doi.org/10.1007/BF01718309

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01718309

Keywords

Search

Navigation